A detailed history of West Paces Advisors Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 8 shares of TMDX stock, worth $575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$575
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$59.28 - $144.9 $474 - $1,159
8 New
8 $499,000
Q1 2024

Apr 15, 2024

BUY
$70.86 - $89.93 $1,417 - $1,798
20 New
20 $1.48 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.29B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.